ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.


Hierarchy:	Medical Subject Headings (MeSH) ∟ Heterocyclic Compounds ∟ Heterocyclic Compounds, 1-Ring ∟ Azoles ∟ Thiazoles ∟ Famotidine 21 coordinate concepts ∟ Benzothiazoles \| ∟ Chlormethiazole \| ∟ Dithiazanine \| ∟ Ethoxzolamide \| ∟ FANFT \| ∟ Firefly Luciferin \| ∟ Levamisole \| ∟ Niridazole \| ∟ Nizatidine \| ∟ Oxythiamine \| ∟ Rhodanine \| ∟ Riluzole \| ∟ Ritonavir \| ∟ Saccharin \| ∟ Sulfathiazoles \| ∟ Tetramisole \| ∟ Thiabendazole \| ∟ Thiadiazoles \| ∟ Thiamine \| ∟ Thiazolidinediones \| ∟ Thiazolidines Medical Subject Headings (MeSH) ∟ Inorganic Chemicals ∟ Sulfur Compounds ∟ Thiazoles ∟ Famotidine 21 coordinate concepts ∟ Benzothiazoles \| ∟ Chlormethiazole \| ∟ Dithiazanine \| ∟ Ethoxzolamide \| ∟ FANFT \| ∟ Firefly Luciferin \| ∟ Levamisole \| ∟ Niridazole \| ∟ Nizatidine \| ∟ Oxythiamine \| ∟ Rhodanine \| ∟ Riluzole \| ∟ Ritonavir \| ∟ Saccharin \| ∟ Sulfathiazoles \| ∟ Tetramisole \| ∟ Thiabendazole \| ∟ Thiadiazoles \| ∟ Thiamine \| ∟ Thiazolidinediones \| ∟ Thiazolidines Medical Subject Headings (MeSH) ∟ Organic Chemicals ∟ Sulfur Compounds ∟ Thiazoles ∟ Famotidine 21 coordinate concepts ∟ Benzothiazoles \| ∟ Chlormethiazole \| ∟ Dithiazanine \| ∟ Ethoxzolamide \| ∟ FANFT \| ∟ Firefly Luciferin \| ∟ Levamisole \| ∟ Niridazole \| ∟ Nizatidine \| ∟ Oxythiamine \| ∟ Rhodanine \| ∟ Riluzole \| ∟ Ritonavir \| ∟ Saccharin \| ∟ Sulfathiazoles \| ∟ Tetramisole \| ∟ Thiabendazole \| ∟ Thiadiazoles \| ∟ Thiamine \| ∟ Thiazolidinediones \| ∟ Thiazolidines X
Broader terms:	Medical Subject Headings (MeSH) ∟ Heterocyclic Compounds ∟ Heterocyclic Compounds, 1-Ring ∟ Azoles ∟ Thiazoles ∟ Famotidine Medical Subject Headings (MeSH) ∟ Inorganic Chemicals ∟ Sulfur Compounds ∟ Thiazoles ∟ Famotidine Medical Subject Headings (MeSH) ∟ Organic Chemicals ∟ Sulfur Compounds ∟ Thiazoles ∟ Famotidine Thiazoles > Azoles > Heterocyclic Compounds, 1-Ring > Heterocyclic Compounds > Medical Subject Headings (MeSH) Thiazoles > Sulfur Compounds > Inorganic Chemicals > Medical Subject Headings (MeSH) Thiazoles > Sulfur Compounds > Organic Chemicals > Medical Subject Headings (MeSH) X
History note:	Anti-Ulcer Agents (1977-1989) \| Histamine H2 Receptor Blockaders (1977-1989) \| Thiazoles (1966-1989)X
historyNote*:	90 X
publicMeSHNote*:	90 X
Scope note:	A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. X
activeMeSHYear*:	2006 \| 2007X
dateCreated*:	1989-05-15X
dateEstablished*:	1990-01-01X
dateRevised*:	2005-06-30X
recordAuthorizer*:	sjnX
recordMaintainer*:	ssbX
recordOriginator*:	RLSX
Type:	Concept X
Coordinate terms:	Benzothiazoles \| Chlormethiazole \| Dithiazanine \| Ethoxzolamide \| FANFT \| Firefly Luciferin \| Levamisole \| Niridazole \| Nizatidine \| Oxythiamine \| Rhodanine \| Riluzole \| Ritonavir \| Saccharin \| Sulfathiazoles \| Tetramisole \| Thiabendazole \| Thiadiazoles \| Thiamine \| Thiazolidinediones \| Thiazolidines X
URI:	X
Labels and equivalent concepts:	Famotidiini (fi) Famotidin (sv) Pepcid (sv, replaced) X
Share:	X